AFT-EndoMAP

A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Recurrent or Persistent Endometrial Cancer
Status:

Open

Trial Type:

Contact:

Dr. Don Dizon
don_dizon@brown.edu